In Morocco, the insulin dosage market size per capita in 2023 stood at $1.13. Over the period from 2013 to 2023, the market experienced fluctuations, initially declining from 2013 to 2015, before entering a phase of modest growth and stability from 2016 onward. The most notable yearly increases occurred between 2019 to 2020 with a 5.41% rise, and from 2020 to 2021 with a 5.13% growth. The past five-year Compound Annual Growth Rate (CAGR) registered a slight decrease at approximately 0.36%, indicating overall stability with slight downward pressure in recent years.
Future trends to watch for include potential market impacts from policy changes in healthcare coverage, technological advancements in diabetes management, and shifts in population demographics leading to increased demand for insulin therapies. Economic factors and innovations in production could also influence market dynamics.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 20 | 20 China | 3.49 | 2023 | View data | ||
| 21 | 21 South Africa | 3.11 | 2023 | View data | ||
| 22 | 22 Morocco | 1.13 | 2023 | |||
